Matches in Wikidata for { <http://www.wikidata.org/entity/Q35154728> ?p ?o ?g. }
- Q35154728 description "2014 nî lūn-bûn" @default.
- Q35154728 description "2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q35154728 description "2014 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q35154728 description "2014年の論文" @default.
- Q35154728 description "2014年論文" @default.
- Q35154728 description "2014年論文" @default.
- Q35154728 description "2014年論文" @default.
- Q35154728 description "2014年論文" @default.
- Q35154728 description "2014年論文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014年论文" @default.
- Q35154728 description "2014년 논문" @default.
- Q35154728 description "article científic" @default.
- Q35154728 description "article scientific" @default.
- Q35154728 description "article scientifique (publié 2014)" @default.
- Q35154728 description "articol științific" @default.
- Q35154728 description "articolo scientifico" @default.
- Q35154728 description "artigo científico (publicado na 2014)" @default.
- Q35154728 description "artigo científico (publicado na 2014)" @default.
- Q35154728 description "artigo científico" @default.
- Q35154728 description "artikull shkencor" @default.
- Q35154728 description "artikulong pang-agham" @default.
- Q35154728 description "artykuł naukowy" @default.
- Q35154728 description "artículo científico publicado en 2014" @default.
- Q35154728 description "artículu científicu espublizáu en 2014" @default.
- Q35154728 description "bilimsel makale" @default.
- Q35154728 description "bài báo khoa học" @default.
- Q35154728 description "mokslinis straipsnis" @default.
- Q35154728 description "naučni članak" @default.
- Q35154728 description "scienca artikolo" @default.
- Q35154728 description "scientific article" @default.
- Q35154728 description "teaduslik artikkel" @default.
- Q35154728 description "tieteellinen artikkeli" @default.
- Q35154728 description "tudományos cikk" @default.
- Q35154728 description "vedecký článok" @default.
- Q35154728 description "vetenskaplig artikel" @default.
- Q35154728 description "videnskabelig artikel (udgivet 2014)" @default.
- Q35154728 description "vitenskapelig artikkel" @default.
- Q35154728 description "vitskapeleg artikkel" @default.
- Q35154728 description "vědecký článek" @default.
- Q35154728 description "wetenschappelijk artikel" @default.
- Q35154728 description "wissenschaftlicher Artikel" @default.
- Q35154728 description "επιστημονικό άρθρο" @default.
- Q35154728 description "мақолаи илмӣ" @default.
- Q35154728 description "мақолаи илмӣ" @default.
- Q35154728 description "наукова стаття, опублікована у квітні 2014" @default.
- Q35154728 description "научна статия" @default.
- Q35154728 description "научная статья" @default.
- Q35154728 description "научни чланак" @default.
- Q35154728 description "научни чланак" @default.
- Q35154728 description "מאמר מדעי" @default.
- Q35154728 description "سائنسی مضمون" @default.
- Q35154728 description "مقالة علمية" @default.
- Q35154728 description "مقالهٔ علمی" @default.
- Q35154728 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q35154728 description "บทความทางวิทยาศาสตร์" @default.
- Q35154728 description "სამეცნიერო სტატია" @default.
- Q35154728 name "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 name "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 name "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 type Item @default.
- Q35154728 label "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 label "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 label "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 prefLabel "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 prefLabel "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 prefLabel "Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese" @default.
- Q35154728 P1433 Q35154728-A3817CD0-B7FC-432A-88DE-F3527ED5E656 @default.
- Q35154728 P1476 Q35154728-701B280E-3211-48F0-9191-14DACF2552F2 @default.
- Q35154728 P2093 Q35154728-0BEC2185-C9D6-4F73-A6AA-9309449BFE02 @default.
- Q35154728 P2093 Q35154728-24A65A49-B7A3-45EA-BF88-A9ECF280FA86 @default.
- Q35154728 P2093 Q35154728-52E48346-244C-46CB-ABB8-33DA2732D1D0 @default.
- Q35154728 P2093 Q35154728-66632418-7CCC-47E3-A9A1-54B4E5FBD68F @default.
- Q35154728 P2093 Q35154728-7F781CA3-9CA5-4BD6-BC11-E16505BF3059 @default.
- Q35154728 P2093 Q35154728-A52C28BE-5B13-4B0C-9115-C4A6FDC4FE2C @default.
- Q35154728 P2093 Q35154728-A6964B49-CCBF-4BAC-8EC2-7EE2470685D2 @default.
- Q35154728 P2093 Q35154728-B49913ED-E18B-472D-BD9D-6E59C80CEED7 @default.
- Q35154728 P2093 Q35154728-C1A86866-DDF6-497E-9E61-ABA330141A2B @default.
- Q35154728 P2093 Q35154728-D085F71B-D9B6-4AF0-94ED-1B1EF8ADB942 @default.
- Q35154728 P2860 Q35154728-1AC41E50-C1A9-42D8-A26A-AEE11263D0C5 @default.
- Q35154728 P2860 Q35154728-1C1A28A9-C421-435D-9F37-60D5CDCD7D3E @default.
- Q35154728 P2860 Q35154728-27B4DB1B-FD96-4ECB-899F-B6F52FBDAD56 @default.
- Q35154728 P2860 Q35154728-2BAD39C8-E7D5-4FD3-98A1-7D4439953EE6 @default.
- Q35154728 P2860 Q35154728-3476A153-4C10-4BFB-AC3A-77E0215CDE4D @default.
- Q35154728 P2860 Q35154728-34CCD86E-304B-4E73-893B-0A2BE3621ECD @default.
- Q35154728 P2860 Q35154728-35F78F82-E2AE-4542-B764-5DEBD91395C4 @default.
- Q35154728 P2860 Q35154728-3B066A86-D3DB-4321-9408-C456BEB5A928 @default.
- Q35154728 P2860 Q35154728-42B2A283-0A93-42CD-92AB-2AC5BC4EC81F @default.
- Q35154728 P2860 Q35154728-44FEC10A-4126-4108-8E63-19CA75ED8238 @default.
- Q35154728 P2860 Q35154728-799E2424-3E5B-4AD3-B9E0-66850E3763C2 @default.
- Q35154728 P2860 Q35154728-8B7B7038-4FC4-4EF1-BE21-004A21D6E7C6 @default.
- Q35154728 P2860 Q35154728-8EAF63C9-1D3A-44D3-9BB3-76FDCF31DE86 @default.
- Q35154728 P2860 Q35154728-A98D8688-852C-4C64-A529-881096C104A3 @default.
- Q35154728 P2860 Q35154728-AFE20A20-ECCC-40E6-8176-9008F629C6F5 @default.
- Q35154728 P2860 Q35154728-BBC85511-FB84-4AC9-865B-ACA5864D3C6D @default.
- Q35154728 P2860 Q35154728-BBE5688D-A2ED-4015-84D3-4A3C6925CCC0 @default.